NEWS

Title Oracle Medical Group invests in filler company TenBio
After investment, company name changed from Regen Biocharm to TenBio
Key product ‘Ecophil’ ensures safety by not using toxic solvents

Oracle Medical Group announced on the 19th that it had invested in Regen Biocharm, a company that manufactures hyaluronic acid (HA) filler, poly L-lactic acid (PLLA), and thread.

After this investment, Regen Biocharm's company name was changed to 'TenBio'. TENBIO’s main product is ‘Ecophil’. It is currently being exported with an export permit, and non-clinical trials are also in progress.

Usually, PLLA is manufactured using solvents, but Ecofill's feature is that it manufactures the product (PLLA) without using solvents. Another strength is that it improves patient safety by not using toxic solvents. In addition, it does not require a process to remove solvents, is beneficial to the health of the manufacturer, and is an eco-friendly manufacturing method. In particular, we hold a patent for the manufacturing method of PLLA products that do not use solvents.

An official from Oracle Medical Group said, "TenBio's other products include a temperature-sensitive anti-adhesion agent, which is currently in research and development and holds related patents," and added, "We are also manufacturing and selling about 2,000 actual products, and are selling them in Korea, Europe, and other countries." “We have a medical device license in Indonesia,” he said.
Hits # 37 Date 2024.03.19

Contact Us

If you have any questions, please call me anytime.

+82-31-698-4785